6 past transactions

gyde

Seed Round in 2022
Gyde offers digital micro-learning and cross-company coaching for managers. Gyde builds a fully digital talent development solution that enables employees to learn through app-based microlearning and peer coaching sessions. They connect employees with peers from other companies to foster a steep learning curve through social learning.

Deep Care

Seed Round in 2022
Deep Care develops healthy habits alongside work to achieve individual goals. They optimize habits with personalized coaching. They provide the extensive data concept jointly developed by Fraunhofer IOSB and FZI.

Uptempo

Series C in 2018
Uptempo is the software provider for effective Marketing Resource Management (MRM). The company gives enterprise marketers the visibility and control to optimize their marketing operations. The enterprise-level MRM solution turns marketing into a business-building powerhouse by letting marketing leaders get on top of their budgets, people workflows, campaigns, and marketplace performance. The company's all-in-one modular marketing suite covers the entire marketing process, including planning, budgeting, creation, development, and asset management, by analyzing content and providing performance reviews in a closed loop, allowing medium and large organizations to keep team members, suppliers, and partners aligned and marketing productivity to increase.

Uptempo

Series B in 2017
Uptempo is the software provider for effective Marketing Resource Management (MRM). The company gives enterprise marketers the visibility and control to optimize their marketing operations. The enterprise-level MRM solution turns marketing into a business-building powerhouse by letting marketing leaders get on top of their budgets, people workflows, campaigns, and marketplace performance. The company's all-in-one modular marketing suite covers the entire marketing process, including planning, budgeting, creation, development, and asset management, by analyzing content and providing performance reviews in a closed loop, allowing medium and large organizations to keep team members, suppliers, and partners aligned and marketing productivity to increase.

amcure

Series B in 2016
amcure is a privately held, clinical-stage company developing peptide-based compounds for the treatment of highly metastatic forms of squamous cancer. Established in 2012, amcure GmbH is a spin-off from the Karlsruhe Institute of Technology (KIT) and is supported by a grant from the German Federal Ministry of Education and Research. amcure leverages its in-depth knowledge of CD44 target biology to develop a novel therapeutic approach to treat metastatic squamous tumors. In cancer, blocking the extracellular target CD44v6 has a beneficial effect on several relevant receptor tyrosine kinase pathways. Their first-in-class CD44v6-inhibitor AMC303 entered clinical development in solid tumors in Q4 2016.

Onventis

Venture Round in 2015
Onventis is develops cloud based e-procurement solutions for supplier relationship management and vendor managed procurement. It offers a portfolio of solutions, including TradeCore Buyer, an integrated cloud-based procurement platform for supplier management, sourcing, order management, and analytics; TradeCore Vendor, a sales tool for wholesalers of indirect goods that include integrated order management, mobile ordering and approval options, catalog management, and reliable analysis functions; and TradeCore Provider, a multi-client solution for group procurement and collaborative commerce.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.